Healthcare Sector and Stocks Analysis from Seeking Alpha
Wed, 8 Aug 2012
Savient Pharmaceuticals, Inc. ( SVNT ) Q2 2012 Earnings Call August 08, 2012 09:00 a.m. ET Executives Louis Ferrari – President and Chief Executive Officer Richard Crowley – EVP, Biopharmaceutical Operations Philip Yachmetz – SVP, General Counsel Kenneth Bahrt – SVP, Chief Medical Officer David ...
Independent. Insightful. Trusted. Morningstar provides stock market analysis; equity, mutual fund, and ETF research, ratings, and picks; portfolio tools; and option, hedge fund, IRA, 401k, and 529 plan research. Our reliable data and analysis can help both experienced enthusiasts and newcomers.